Cargando…
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-termi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714343/ https://www.ncbi.nlm.nih.gov/pubmed/33270715 http://dx.doi.org/10.1371/journal.pone.0243213 |
_version_ | 1783618735860350976 |
---|---|
author | Jones, Erika Wei, Janet Nelson, Michael D. Bakir, May Mehta, Puja K. Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J. Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel |
author_facet | Jones, Erika Wei, Janet Nelson, Michael D. Bakir, May Mehta, Puja K. Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J. Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel |
author_sort | Jones, Erika |
collection | PubMed |
description | BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. METHODS: We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. RESULTS: Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). CONCLUSION: Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF. |
format | Online Article Text |
id | pubmed-7714343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77143432020-12-09 N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study Jones, Erika Wei, Janet Nelson, Michael D. Bakir, May Mehta, Puja K. Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J. Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel PLoS One Research Article BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. METHODS: We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. RESULTS: Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). CONCLUSION: Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF. Public Library of Science 2020-12-03 /pmc/articles/PMC7714343/ /pubmed/33270715 http://dx.doi.org/10.1371/journal.pone.0243213 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Jones, Erika Wei, Janet Nelson, Michael D. Bakir, May Mehta, Puja K. Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J. Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title_full | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title_fullStr | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title_full_unstemmed | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title_short | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study |
title_sort | n-terminal pro-b-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: a report from the women’s ischemia syndrome evaluation–coronary vascular dysfunction (wise-cvd) study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714343/ https://www.ncbi.nlm.nih.gov/pubmed/33270715 http://dx.doi.org/10.1371/journal.pone.0243213 |
work_keys_str_mv | AT joneserika nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT weijanet nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT nelsonmichaeld nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT bakirmay nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT mehtapujak nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT shufeltchrisandra nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT minissianmargo nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT sharifbehzad nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT pepinecarlj nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT handbergeileen nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT cookwiensgalen nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT sopkogeorge nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy AT baireymerzcnoel nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy |